Edward Kim, MD

Professor of Radiology
Mount Sinai Health System

Presentation(s):

• Radioembolization plus Immune Checkpoint Inhibitor Therapy compared to Radioembolization plus Tyrosine Kinase Inhibitor Therapy for the Treatment of Hepatocellular Carcinoma

  Sunday, March 5, 2023
  3:18 PM – 3:27 PM

  Disclosure information not submitted.

• TARE for Y90: Latest trials

  Monday, March 6, 2023
  9:20 AM – 9:30 AM

  Disclosure information not submitted.

• HCC: East meets West

  Monday, March 6, 2023
  3:00 PM – 4:30 PM

  Disclosure information not submitted.

• Early-Stage HCC when ablation is not an option: Western perspective

  Monday, March 6, 2023
  3:30 PM – 3:40 PM

  Disclosure information not submitted.

• Panel Discussion

  Monday, March 6, 2023
  3:40 PM – 3:50 PM

  Disclosure information not submitted.

• Radioembolization Prior to Checkpoint Inhibitor Immunotherapy versus Radioembolization Post Checkpoint Inhibitor Immunotherapy for the Treatment of Intermediate and Advanced Stage Hepatocellular Carcinoma

  Monday, March 6, 2023
  3:36 PM – 3:45 PM

  Disclosure information not submitted.

• Y-90 vs. TACE Histopathologic Outcomes in Patients with HCC Who Underwent Orthotopic Liver Transplant: A Single-Center, 7-Year Experience

  Monday, March 6, 2023
  3:45 PM – 3:54 PM

  Disclosure information not submitted.

• Geniculate Artery Embolization: Vascular Anatomy and Technical Considerations

  Monday, March 6, 2023
  5:40 PM – 5:45 PM

  Disclosure information not submitted.

• Percutaneous Cholecystocholangiography for Early Exclusion of Biliary Atresia: A Single Center 5-Year Experience

  Tuesday, March 7, 2023
  3:27 PM – 3:36 PM

  Disclosure information not submitted.